
### [MONDO:0000192](http://purl.obolibrary.org/obo/MONDO_0000192)
**Label:** polyglucosan body myopathy

**Subclasses:** [MONDO:0014389](http://purl.obolibrary.org/obo/MONDO_0014389) (polyglucosan body myopathy 1 with or without immunodeficiency), [MONDO:0018348](http://purl.obolibrary.org/obo/MONDO_0018348) (polyglucosan body myopathy type 1), [MONDO:0017992](http://purl.obolibrary.org/obo/MONDO_0017992) (autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis), [MONDO:0014526](http://purl.obolibrary.org/obo/MONDO_0014526) (polyglucosan body myopathy type 2), 

**Corr. equiv. classes:** [OMIM:615895](http://purl.obolibrary.org/obo/OMIM_615895), [Orphanet:329173](http://www.orpha.net/ORDO/Orphanet_329173), [OMIM:616199](http://purl.obolibrary.org/obo/OMIM_616199), [Orphanet:456369](http://www.orpha.net/ORDO/Orphanet_456369), [Orphanet:397937](http://www.orpha.net/ORDO/Orphanet_397937), 

**Class expressions from DL-Learner:**

- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 22.49%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 22.48%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 22.47%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 22.47%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 21.43%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 21.26%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 20.72%
- Thing 20.72%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 20.72%


